Hosted on MSN4m
Report Reveals Billions Made from Generic Drug Price HikesA recent Federal Trade Commission report highlights a concerning trend in the pharmaceutical industry, where pharmacy benefit ...
UnitedHealth’s net income plummeted to its lowest level since 2019 amid hefty costs, including some from the Change ...
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands ...
The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases ...
A new research report from Colliers finds that the role of retail pharmacies has changed over time, moving far beyond roles ...
UnitedHealth Group posted mixed Q4 results, with EPS beating estimates and revenue falling short. The company reaffirmed its ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...
The "Big 3" PBMs also separately generated an estimated $1.4 billion of income from spread pricing, FTC finds.
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback